Alliance for Clinical Trials in Oncology

Recent papers from Alliance for Clinical Trials in Oncology

1. Treatment-related neutropenia as predictor of response to adjuvant palbociclib in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109)JNCI Journal of the National Cancer Institute · 2026
2. Flavonoids and survival in stage III colon cancer: CALGB/SWOG 80702 (alliance)JNCI Cancer Spectrum · 2026
3. Risk Factors Associated With Positive Intraoperative Valve Tissue Cultures and the Subsequent Impact on Infective Endocarditis Management and OutcomesOpen Forum Infectious Diseases · 2026
4. Metabolic Signatures Associated with COVID-19 Vaccination in Serum from Healthy IndividualsVaccines · 2026
5. Pacemaker-implantation and atrioventricular-node ablation vs pulmonary vein isolation for elderly patients with persistent atrial fibrillation: the ABLATE versus PACE trialEuropean Heart Journal · 2026
6. Phase 2 Study of Futibatinib in Combination with Pembrolizumab in Patients with FGF19 expressing Advanced Hepatocellular CarcinomaThe Oncologist · 2026
7. Clinical Value of MRI in Radiation-Associated Angiosarcoma of the Breast: Assessment of Baseline and Post-Neoadjuvant DiseaseBritish Journal of Radiology · 2026
8. Prevalence and risk factors of malnutrition in elderly patients with diabetes mellitus: a meta-analysis and systematic reviewFrontiers in Nutrition · 2026
9. “It’s Scary, but I Handle It”: A Qualitative Study on Severe Hypoglycemia Experiences and Reasons for Declining to Participate in a Community Paramedicine Trial to Prevent Hypoglycemia Among People With DiabetesDiabetes Obesity and Cardiometabolic CARE · 2026
10. Global Burden of Elevated LDL-CJAMA · 2026
11. Standardization of postoperative adverse event reporting: A critical opportunity for improvement within the National Clinical Trials NetworkCancer · 2026
12. Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study)Mayo Clinic Proceedings Innovations Quality & Outcomes · 2026
13. Development of a nalmefene formulation suitable for a community‐use auto‐injectorBritish Journal of Clinical Pharmacology · 2026
14. Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 TrialsBritish Journal of Dermatology · 2026
15. Laparoscopic versus open surgery for rectal cancer: individual patient data meta-analysis of the ALaCaRT and Z6051 randomized trialsBJS Open · 2026
16. Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naïve CLL/SLLLeukemia & lymphoma/Leukemia and lymphoma · 2026
17. Glucagon-like peptide-1 receptor agonists are associated with cardiac, cancer- and mortality-related benefits in diabetic patients treated with anthracyclinesEuropean Heart Journal Open · 2026
18. ID #950 CURE-ETMR, a Prospective, International, Molecularly Guided Trial Utilizing Centralized Screening and Risk-Adapted Assignment for Infants with Rare Embryonal Brain TumorsNeuro-Oncology Pediatrics · 2026
19. Comparative Performance of Electrodiagnostic Criteria in Guillain-Barré Syndrome and the Impact of Machine-assisted Analysis (P1-9.001)Neurology · 2026
20. Adult ADHD as a Potential Risk Factor for Dementia: A Scoping Review (P10-13.014)Neurology · 2026